<p>Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.  </p>

Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.

<p>Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now. &nbsp;</p>

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

"The Exchange" on CNBC is a one-stop shop for the day's top business stories, along with breaking news and the must-see market movers heading into the back half of the trading day. This newsroom-based program also features lots of original reporting, in-depth conversations and showcases CNBC's award-winning investigative work.

Share A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

Sign up to save your podcasts

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

More shows like The Exchange

Mad Money w/ Jim Cramer

CNBC's "Fast Money"

CNBC's "Options Action"

Your Money Minute

Exchanges

Fortt Knox

Strange Success with Jane Wells

American Greed Podcast

Thoughts on the Market

Squawk on the Street

Squawk Pod

The Keynote by CNBC Events

Barron's Live

Halftime Report

CNBC's "Last Call"

Worldwide Exchange

RiskReversal Pod

MRKT Matrix

TechCheck

Closing Bell

Power Lunch

Manifest Space with Morgan Brennan

CNBC’s “Money Movers”

CNBC Business News Update

The Crimes of Putin’s Trader

CNBC Sport